Framingham Centro Médico

La Plata, Buenos Aires B1902COS

0 studies enrolling now · 6 studies all time

What they study most

Diffuse Cutaneous Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis, Sclerosis, Systemic, Sjogren's Syndrome, Sjögren's Syndrome (SS), Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
• A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
• An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) — Stopped early
• Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) — Stopped early
• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed